EUR 2.7
(7.14%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 4.09 Million | 4.86 Million | 4.56 Million | 2.14 Million |
Cost of Revenue | 4.01 Million | 2.74 Million | 2.68 Million | 1.51 Million |
Gross Profit | 78.95 Thousand | 2.11 Million | 1.87 Million | 631.87 Thousand |
Operating Expenses | 2.05 Million | 2.62 Million | 991.32 Thousand | 837.87 Thousand |
Selling, General and Administrative Expenses | 281.53 Thousand | 201.07 Thousand | 64.83 Thousand | - |
Research and Development Expenses | - | - | - | - |
Other Expenses | 1.77 Million | - | - | - |
Cost and Expenses | 6.07 Million | 5.37 Million | 3.68 Million | 2.34 Million |
Operating Income | -1.97 Million | -537.23 Thousand | 1.01 Million | -192.04 Thousand |
Interest Expense | 140.74 Thousand | 217.04 Thousand | 64.18 Thousand | 48.05 Thousand |
Income Tax Expense | 569.63 Thousand | 194.14 Thousand | 251.26 Thousand | -38.17 Thousand |
Earnings before Tax | -2.19 Million | -765.02 Thousand | 734.85 Thousand | -153.18 Thousand |
Net Income | -1.56 Million | -541.34 Thousand | 560.43 Thousand | -115 Thousand |
Earnings Per Share Basic | -0.30 | -0.18 | 0.11 | -0.02 |
Earnings Per Share Diluted | -0.30 | -0.18 | 0.11 | -0.02 |
Weighted Average Shares Outstanding | 5.19 Million | 3.06 Million | 5.19 Million | 5.19 Million |
Weighted Average Shares Outstanding (Diluted) | 5.19 Million | 3.06 Million | 5.19 Million | 5.19 Million |
Gross Margin | 0.02 | 0.43 | 0.41 | 0.29 |
EBIT Margin | -0.34 | -0.07 | 0.26 | -0.05 |
Profit Margin | -0.38 | -0.11 | 0.12 | -0.05 |
EBITDA | -1.38 Million | -311.06 Thousand | 1.18 Million | -110.43 Thousand |
Earnings Before Tax Margin | -0.48 | -0.11 | 0.22 | -0.09 |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | 1.53 Million | 4.09 Million | 1.53 Million | 1.04 Million | 1.04 Million | 1.07 Million |
Cost of Revenue | 638.03 Thousand | 4.01 Million | 638.03 Thousand | 1.2 Million | 1.2 Million | 457.54 Thousand |
Gross Profit | 893.76 Thousand | 78.95 Thousand | 893.76 Thousand | -158.49 Thousand | -158.49 Thousand | 615.8 Thousand |
Operating Expenses | 1.35 Million | 2.12 Million | 1.35 Million | 368.39 Thousand | 368.39 Thousand | 923.41 Thousand |
Selling, General and Administrative Expenses | 798.3 Thousand | - | 798.3 Thousand | 618.92 Thousand | 618.92 Thousand | 548.21 Thousand |
Research and Development Expenses | 21.48 Thousand | - | 21.48 Thousand | 1537.00 | 1537.00 | - |
Other Expenses | 536.35 Thousand | - | 536.35 Thousand | -252.06 Thousand | -252.06 Thousand | 375.19 Thousand |
Cost and Expenses | 1.99 Million | 6.14 Million | 1.99 Million | 1.57 Million | 1.57 Million | 1.38 Million |
Operating Income | -462.37 Thousand | -1.97 Million | -462.37 Thousand | -526.89 Thousand | -526.89 Thousand | -307.6 Thousand |
Interest Expense | - | 140.74 Thousand | - | - | - | - |
Income Tax Expense | 155.46 Thousand | 569.63 Thousand | 155.46 Thousand | 129.35 Thousand | 129.35 Thousand | 72.18 Thousand |
Earnings before Tax | -534.9 Thousand | -2.18 Million | -534.9 Thousand | -564.8 Thousand | -564.8 Thousand | -351.04 Thousand |
Net Income | -354.86 Thousand | -1.56 Million | -354.86 Thousand | -426.71 Thousand | -426.71 Thousand | -271.7 Thousand |
Earnings Per Share Basic | -0.07 | - | -0.07 | -0.08 | -0.08 | -0.05 |
Earnings Per Share Diluted | -0.07 | - | -0.07 | -0.08 | -0.08 | -0.05 |
Weighted Average Shares Outstanding | 5.19 Million | 5.19 Million | 5.19 Million | 5.19 Million | 5.19 Million | 5.19 Million |
Weighted Average Shares Outstanding (Diluted) | 5.19 Million | 5.19 Million | 5.19 Million | 5.19 Million | 5.19 Million | 5.19 Million |
Gross Margin | 0.58 | 0.02 | 0.58 | -0.15 | -0.15 | 0.57 |
EBIT Margin | -0.20 | - | -0.20 | -0.41 | -0.41 | -0.23 |
Profit Margin | -0.23 | -0.38 | -0.23 | -0.41 | -0.41 | -0.25 |
EBITDA | -302.97 Thousand | - | -302.97 Thousand | -435.12 Thousand | -435.12 Thousand | -251.01 Thousand |
Earnings Before Tax Margin | -0.30 | -0.48 | -0.30 | -0.50 | -0.50 | -0.29 |
HNORY
5013
FNMAO
7988
LLEIF
AMIN